
AI-powered clinical decision support platform used by 760,000+ physicians.
OpenEvidence (Xyla Inc.) is an AI-powered clinical decision support platform that aggregates, synthesizes, and visualizes peer-reviewed medical research for healthcare professionals. Founded in 2021 and headquartered in Miami, Florida, the platform is used by over 760,000 registered physicians—representing more than 40% of U.S. doctors—to stay current with the latest clinical evidence and research literature. The company leverages artificial intelligence and machine learning to combat information overload in medicine and enhance patient care.
OpenEvidence is a Mayo Clinic Platform Accelerate Company and has partnered with Elsevier to launch ClinicalKey AI, integrating trusted content from prominent medical journals and resources. Notable affiliations include Ram Dandillaya of Cedars-Sinai, Antonio Forte of Mayo Clinic, John Lee of Harvard Medical School, and Nobel Laureate Daniel Kahneman. The company has raised approximately $735 million in total funding and was valued at $12 billion as of January 2026, with reported annual recurring revenue of $150 million as of December 2025.

Doctor Evidence
doctorevidence.com

Vera Health
verahealth.ai

Evidentia Health

Researchably
researchably.com

Hippocratic AI
hippocraticai.com

Outcomes4Me

EvidenceCare
evidence.care

Glass Health
glass.health

Evidium

Gesund
gesund.ai

DocMatter
docmatter.com

Evidation Health
evidation.com

Truveta
truveta.com

Docus
docus.ai

Medeloop
medeloop.ai
Companies similar to OpenEvidence include Doctor Evidence, Vera Health, Evidentia Health and Researchably.
OpenEvidence was founded in 2021.
OpenEvidence's headquarters is located in Miami, FL, US.
OpenEvidence's most recent funding round was for $250M (USD) in January 2026.
As of Jan 21, 2026, OpenEvidence has raised a total of $630M (USD).
OpenEvidence has 30 employees as of May 10, 2026.